Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Formation of a free acyl adenylate during the activation of 2-propylpentanoic acid. Valproyl-AMP: a novel cellular metabolite of valproic acid
1992
Mao, L.F.; Millington, D.S.; Schulz, H.
J. Biol. Chem.
267
3143-3146
Inhibition and activation studies on sheep liver sorbitol dehydrogenase
1994
Lindstad, R.I.; Hermansen, L.F.; McKinley-McKee, J.S.
Eur. J. Biochem.
221
847-854
Purification and characterization of a novel dimeric 20alpha-hydroxysteroid dehydrogenase from Tetrahymena pyriformis
1994
Inazu, A.; Sato, K.; Nakayama, T.; Deyashiki, Y.; Hara, A.; Nozawa, Y.
Biochem. J.
297
195-200
Inhibition of hexonate dehydrogenase and aldose reductase from bovine retina by sorbinil, statil, M79175 and valproate
1986
Poulsom, R.
Biochem. Pharmacol.
35
2955-2959
Subcellular distribution of succinate-semialdehyde dehydrogenase in rat brain
1973
Sims, K.L.; Davis, G.A.
Eur. J. Biochem.
35
450-453
The alpha-ketoglutarate dehydrogenase complex in neurodegeneration
2000
Gibson, G.E.; Park, L.C.H.; Sheu, K.F.R.; Blass, J.P.; Calingasan, N.Y.
Neurochem. Int.
36
97-112
Aldehyde dehydrogenase (CoA-acetylating) and the mechanism of ethanol formation in the amitochondriate protist, Giardia lamblia
1998
Sanchez, L.B.
Arch. Biochem. Biophys.
354
57-64
Glucuronidation of opioids, carboxylic acid-containing drugs, and hydroxylated xenobiotics catalyzed by expressed monkey UDP-glucuronosyltransferase 2B9 protein
1997
Green, M.D.; Belanger, G.; Hum, D.W.; Belanger, A.; Tephly, T.R.
Drug Metab. Dispos.
25
1389-1394
-
Cloning and characterization of a novel human olfactory UDP-glucuronosyltransferase
1999
Jedlitschky, G.; Cassidy, A.J.; Sales, M.; Pratt, N.; Burchell, B.
Biochem. J.
340
837-843
Inhibition of palmitoyl Co-enzyme A hydrolase in mitochondria and microsomes by pharmaceutical organic anions
1990
Dixon, A.; Osterloh, J.; Becker, C.
J. Pharm. Sci.
79
103-105
Characterization of a renal medium chain acyl-CoA synthetase responsible for glycine conjugation in mouse kidney mitochondria
1999
Kasuya, F.; Igarashi, K.; Fukui, M.
Chem. Biol. Interact.
118
233-246
Human 1D-myo-inositol 3-phosphate synthase is functional in yeast
2004
Ju, S.; Shaltiel, G.; Shamir, A.; Agam, G.; Greenberg, M.L.
J. Biol. Chem.
279
21759-21765
Sorbitol dehydrogenase: structure, function and ligand design
2004
El-Kabbani, O.; Darmanin, C.; Chung, R.P.
Curr. Med. Chem.
11
465-476
Cloning and characterisation of the first drug-metabolising canine UDP-glucuronosyltransferase of the 2B subfamily
2003
Soars, M.G.; Fettes, M.; O'Sullivan, A.C.; Riley, R.J.; Ethell, B.T.; Burchell, B.
Biochem. Pharmacol.
65
1251-1259
-
1D-myo-inositol 3-phosphate synthase: conservation, regulation, and putative target of mood stabilizers
2004
Ju, S.; Greenberg, M.L.
Clin. Neurosci. Res.
4
181-187
A new citryl glycoside from Gastrodia elata and its inhibitory activity on GABA transaminase
2006
Choi, J.H.; Lee, D.U.
Chem. Pharm. Bull.
54
1720-1721
Purification, characterization, and mass spectrometric sequencing of a medium chain acyl-CoA synthetase from mouse liver mitochondria and comparisons with the homologs of rat and bovine
2006
Kasuya, F.; Tatsuki, T.; Ohta, M.; Kawai, Y.; Igarashi, K.
Protein Expr. Purif.
47
405-414
Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen
2001
Phiel, C.J.; Zhang, F.; Huang, E.Y.; Guenther, M.G.; Lazar, M.A.; Klein, P.S.
J. Biol. Chem.
276
36734-36741
Structure-function properties of prolyl oligopeptidase family enzymes
2006
Rea, D.; Fueloep, V.
Cell Biochem. Biophys.
44
349-365
Prolyl endopeptidases
2007
Gass, J.; Khosla, C.
Cell. Mol. Life Sci.
64
345-355
Suggested functions for prolyl oligopeptidase: a puzzling paradox
2007
Brandt, I.; Scharpe, S.; Lambeir, A.M.
Clin. Chim. Acta
377
50-61
Structure, function and biological relevance of prolyl oligopeptidase
2008
Szeltner, Z.; Polgar, L.
Curr. Protein Pept. Sci.
9
96-107
Characterization of an oligomeric carbonyl reductase of dog liver: its identity with peroxisomal tetrameric carbonyl reductase
2007
Endo, S.; Matsunaga, T.; Nagano, M.; Abe, H.; Ishikura, S.; Imamura, Y.; Hara, A.
Biol. Pharm. Bull.
30
1787-1791
Serum and liver tissue biotinidase enzyme activity in rats which were administrated to valproic acid
2006
Korkmazer, N.; Vurucu, S.; Demirkaya, E.; Unay, B.; Kul, M.; Akin, R.; Gokcay, E.
Brain Dev.
28
515-520
Valproic acid increases expression of methylenetetrahydrofolate reductase (MTHFR) and induces lower teratogenicity in MTHFR deficiency
2008
Roy, M.; Leclerc, D.; Wu, Q.; Gupta, S.; Kruger, W.D.; Rozen, R.
J. Cell. Biochem.
105
467-476
Early effects of sodium valproate monotherapy on serum paraoxonase/arylesterase activities
2009
Karikas, G.A.; Schulpis, K.H.; Bartzeliotou, A.; Regoutas, S.; Thanopoulou, C.; Papaevangelou, V.; Giannoulia-Karantana, A.; Papassotiriou, I.; Fytou-Pallikari, A.
Scand. J. Clin. Lab. Invest.
69
31-35
New sulfurated derivatives of valproic acid with enhanced histone deacetylase inhibitory activity
2008
Perrino, E.; Cappelletti, G.; Tazzari, V.; Giavini, E.; Del Soldato, P.; Sparatore, A.
Bioorg. Med. Chem. Lett.
18
1893-1897
Isoform-specific histone deacetylase inhibitors: The next step?
2009
Balasubramanian, S.; Verner, E.; Buggy, J.J.
Cancer Lett.
280
211-221
Characterization of a rat NADPH-dependent aldo-keto reductase (AKR1B13) induced by oxidative stress
2009
Endo, S.; Matsunaga, T.; Mamiya, H.; Hara, A.; Kitade, Y.; Tajima, K.; El-Kabbani, O.
Chem. Biol. Interact.
178
151-157
Histone deacetylase 3 (hdac3) is specifically required for liver development in zebrafish
2008
Farooq, M.; Sulochana, K.N.; Pan, X.; To, J.; Sheng, D.; Gong, Z.; Ge, R.
Dev. Biol.
317
336-353
Modulation of histone deacetylase activity by dietary isothiocyanates and allyl sulfides: studies with sulforaphane and garlic organosulfur compounds
2009
Nian, H.; Delage, B.; Ho, E.; Dashwood, R.H.
Environ. Mol. Mutagen.
50
213-221
Development of a high-throughput human hepG2 dual luciferase assay for detection of metabolically activated hepatotoxicants and genotoxicants
2009
Liu, X.; Kramer, J.A.; Hu, Y.; Schmidt, J.M.; Jiang, J.; Wilson, A.G.E.
Int. J. Toxicol.
28
162-179
Simple inhibitors of histone deacetylase activity that combine features of short-chain fatty acid and hydroxamic acid inhibitors
2008
Tischler, J.L.; Abuaita, B.; Cuthpert, S.C.; Fage, C.; Murphy, K.; Saxe, A.; Furr, E.B.; Hedrick, J.; Meyers, J.; Snare, D.; Zand, A.R.
J. Enzyme Inhib. Med. Chem.
23
549-555
Enhanced histone deacetylase enzyme activity in primary myelofibrosis
2008
Wang, J.C.; Chen, C.; Dumlao, T.; Naik, S.; Chang, T.; Xiao, Y.Y.; Sominsky, I.; Burton, J.
Leuk. Lymphoma
49
2321-2327
Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies
2009
Bora-Tatar, G.; Dayangac-Erden, D.; Demir, A.S.; Dalkara, S.; Yelekci, K.; Erdem-Yurter, H.
Bioorg. Med. Chem.
17
5219-5228
Design and synthesis of novel series of pyrrole based chemotypes and their evaluation as selective aldose reductase inhibitors. A case of bioisosterism between a carboxylic acid moiety and that of a tetrazole
2010
Pegklidou, K.; Koukoulitsa, C.; Nicolaou, I.; Demopoulos, V.J.
Bioorg. Med. Chem.
18
2107-2114
Effects of diverse psychopharmacological substances on the activity of brain prolyl oligopeptidase
2011
Peltonen, I.; Maennistoe, P.T.
Basic Clin. Pharmacol. Toxicol.
108
46-54
Synthesis, characterization, hypoglycemic and aldose reductase inhibition activity of arylsulfonylspiro[fluorene-9,5-imidazolidine]-2,4-diones
2015
Iqbal, Z.; Hameed, S.; Ali, S.; Tehseen, Y.; Shahid, M.; Iqbal, J.
Eur. J. Med. Chem.
98
127-138
Drug repurposing of histone deacetylase inhibitors that alleviate neutrophilic inflammation in acute lung injury and idiopathic pulmonary fibrosis via inhibiting leukotriene A4 hydrolase and blocking LTB4 biosynthesis
2017
Lu, W.; Yao, X.; Ouyang, P.; Dong, N.; Wu, D.; Jiang, X.; Wu, Z.; Zhang, C.; Xu, Z.; Tang, Y.; Zou, S.; Liu, M.; Li, J.; Zeng, M.; Lin, P.; Cheng, F.; Huang, J.
J. Med. Chem.
60
1817-1828
Drug repurposing of histone deacetylase inhibitors that alleviate neutrophilic inflammation in acute lung injury and idiopathic pulmonary fibrosis via inhibiting leukotriene A4 hydrolase and blocking LTB4 biosynthesis
2017
Lu, W.; Yao, X.; Ouyang, P.; Dong, N.; Wu, D.; Jiang, X.; Wu, Z.; Zhang, C.; Xu, Z.; Tang, Y.; Zou, S.; Liu, M.; Li, J.; Zeng, M.; Lin, P.; Cheng, F.; Huang, J.
J. Med. Chem.
60
1817-1828
The role of isoaspartate in fibrillation and its prevention by protein-L-isoaspartyl methyltransferase
2019
Chatterjee, T.; Das, G.; Chatterjee, B.K.; Dhar, J.; Ghosh, S.; Chakrabarti, P.
Biochim. Biophys. Acta
1864
129500
The role of isoaspartate in fibrillation and its prevention by protein-L-isoaspartyl methyltransferase
2019
Chatterjee, T.; Das, G.; Chatterjee, B.K.; Dhar, J.; Ghosh, S.; Chakrabarti, P.
Biochim. Biophys. Acta
1864
129500
Valproic acid exposure decreases Cbp/p300 protein expression and histone acetyltransferase activity in P19 cells
2016
Lamparter, C.; Winn, L.
Toxicol. Appl. Pharmacol.
306
69-78
In vitro inhibition of human erythrocyte hexokinase by various hyperglycemic drugs
2017
Aljamal, J.; Badawneh, M.
J. Biochem. Mol. Toxicol.
31
e21910
In vitro inhibition of human erythrocyte hexokinase by various hyperglycemic drugs
2017
Aljamal, J.; Badawneh, M.
J. Biochem. Mol. Toxicol.
31
e21910
Enhancing activity and selectivity in a series of pyrrol-1-yl-1-hydroxypyrazole-based aldose reductase inhibitors The case of trifluoroacetylation
2017
Papastavrou, N.; Chatzopoulou, M.; Ballekova, J.; Cappiello, M.; Moschini, R.; Balestri, F.; Patsilinakos, A.; Ragno, R.; Stefek, M.; Nicolaou, I.
Eur. J. Med. Chem.
130
328-335
In-silico studies on myo inositol-1-phosphate synthase of Leishmania donovani in search of anti-leishmaniasis
2022
Sinha, M.; Jagadeesan, R.; Kumar, N.; Saha, S.; Kothandan, G.; Kumar, D.
J. Biomol. Struct. Dyn.
40
3371-3384
Causes and consequences of impaired methionine synthase activity in acquired and inherited disorders of vitamin B12 metabolism
2022
Gueant, J.L.; Gueant-Rodriguez, R.M.; Kosgei, V.J.; Coelho, D.
Crit. Rev. Biochem. Mol. Biol.
57
133-155
close all tables 
open all tables
top
